The pharmacokinetics and cardiovascular safety of olopatadine in pediatric seasonal allergic rhinitis patients after administration of olopatadine HCL nasal spray

被引：0
|
作者：
Ratner, P. H.
James, A. J.
Orr, S. C.
Martens, K. D.
Dahlin, D. C.
Blair, S. A.
Wall, G. M.
Faulkner, R. D.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2008年 / 100卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：A83 / A83
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of the combination nasal spray olopatadine hydrochloride-mometasone furoate in the treatment of allergic rhinitis
    Klimek L.
    Klimek F.
    Bergmann C.
    Hagemann J.
    Cuevas M.
    Becker S.
    [J]. Allergo Journal International, 2024, 33 (1) : 9 - 19
  • [32] Efficacy and Safety of the Combination Nasal Spray Olopatadine Hydrochloride-Mometasone Furoate in the Treatment of allergic Rhinitis
    Klimek, L.
    Klimek, F.
    Bergmann, C.
    Hagemann, J.
    Cuevas, M.
    Becker, S.
    [J]. ALLERGOLOGIE, 2024, 47 (04)
  • [33] Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 μg in the treatment of seasonal allergic rhinitis
    Kaliner, Michael A.
    Storms, William
    Tilles, Stephen
    Spector, Sheldon
    Tan, Ricardo
    LaForce, Craig
    Lanier, Bobby Q.
    Chipps, Bradley
    [J]. ALLERGY AND ASTHMA PROCEEDINGS, 2009, 30 (03) : 255 - 262
  • [34] OLOPATADINE/MOMETASONE COMBINATION NASAL SPRAY IMPROVES SEASONAL ALLERGIC RHINITIS SYMPTOMS IN A RAGWEED ENVIRONMENTAL EXPOSURE CHAMBER
    Patel, P.
    Salapatek, A.
    Agarwal, P.
    Tantry, S.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S90 - S90
  • [35] Comprehensive report of the efficacy, safety, quality of life, and work impact of Olopatadine 0.6% and Olopatadine 0.4% treatment in patients with seasonal allergic rhinitis
    Fairchild, Carol J.
    Meltzer, Eli O.
    Roland, Peter S.
    Wells, David
    Drake, Margaret
    Wall, G. Michael
    [J]. ALLERGY AND ASTHMA PROCEEDINGS, 2007, 28 (06) : 716 - 723
  • [36] Efficacy and safety of twice-daily and once-daily olopatadine-mometasone combination nasal spray for seasonal allergic rhinitis
    Andrews, Charles P.
    Mohar, Dale
    Salhi, Yacine
    Tantry, Sudeesh K.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 124 (02) : 171 - +
  • [37] Efficacy and Safety of Olopatadine Hydrochloride Nasal Spray, 0.6% in Children 2 to 11 Years of Age with Allergic Rhinitis
    Carr, W.
    Wall, G.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (02) : AB175 - AB175
  • [38] Quality of Life Improvements Following Treatment with Olopatadine/Mometasone Combination Nasal Spray in Patients with Seasonal Allergic Rhinitis: A Pooled Analysis
    Mohar, Dale
    Andrews, Charles P.
    Fernando, Nelumka
    Caracta, Cynthia F.
    Tantry, Sudeesh K.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB63 - AB63
  • [39] Onset of action of olopatadine hydrochloride nasal spray 0.6% (Patanase®) in the treatment of allergic rhinitis
    Patel, P.
    Patel, D.
    Edwards, M.
    Drake, M.
    Garadi, R.
    Wells, D.
    Potts, S.
    Wall, G.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S50 - S50
  • [40] Clinically Meaningful Improvement in Total Rhinoconjunctivitis Score with Olopatadine/mometasone Combination Nasal Spray in Patients with Seasonal Allergic Rhinitis: A Pooled Analysis
    Meltzer, Eli O.
    Wu, Wen
    Christensen, Anne Deen
    Wheeler, Jane
    Aggarwal, Vineet
    Caracta, Cynthia
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
12345